Latest filing published 23 Jan 2026 for Astria Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jonathan Violin: trading record in brief
This profile gathers the share dealings of Jonathan Violin across 2 companies, led by Viridian Therapeutics, Inc.\DE and Astria Therapeutics, Inc. The record holds 17 filings, for trades running from 27 October 2020 to 23 January 2026.
On the market, this insider has only sold: 11 sales, €5.6M in total. The rest of the record consists of 1 option exercise.
The latest filing, published on 23 January 2026, reports a transaction in Astria Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jonathan Violin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 263,321 sharesCommon StockSEC:0000905148-26-000324:0
- 50,000 shares@ US$0.150.2% of flowCommon StockSEC:0000899243-23-004233:0
- 50,000 shares@ US$36.8044.8% of flowCommon StockSEC:0000899243-23-003921:0
- 30,000 shares@ US$12.2010.0% of flowCommon StockSEC:0000899243-22-020717:0
- 30,000 shares@ US$13.0410.8% of flowCommon StockSEC:0000899243-22-016657:0
- 26,400 shares@ US$18.9213.1% of flowCommon StockSEC:0000899243-22-013858:0
- 18,894 shares@ US$17.828.7% of flowCommon StockSEC:0000899243-22-009096:0
- 16,751 shares@ US$19.558.5% of flowCommon StockSEC:0000899243-22-004665:0
- 627,564 shares0Common StockSEC:0000899243-21-047801:0
- 263,321 shares0Common StockSEC:0001104659-21-118359:0
10 of 10 declarations
